NTRA FY 2023 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

FY 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.1B+32.0% YoY

Gross Profit

$493M45.5% margin

Operating Income

-$446M-41.2% margin

Net Income

-$435M-40.2% margin

EPS (Diluted)

$-3.78

Cash Flow

Operating Cash Flow

-$247M

Free Cash Flow

-$286M

Stock-Based Comp.

$192M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$676M

Stockholders' Equity

$765M

Cash & Equivalents

$642M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$820M	+32.0%
Gross Profit	$493M	$364M	+35.4%
Operating Income	-$446M	-$541M	+17.5%
Net Income	-$435M	-$548M	+20.6%